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Hyaluronan is apically secreted and expressed by proliferating
or regenerating renal tubular cells.
Background. Hyaluronan has diverse biologic functions in
the body, varying from structural tasks to cell stress-induced
CD44-mediated activation of intracellular signaling pathways.
Hyaluronan biology is relatively unexplored in the kidney. Pre-
viously, we identified hyaluronan as binding molecule for crys-
tals in the renal tubules. Crystal retention is a crucial early event
in the etiology of kidney stones. The present study was per-
formed to determine the polarized distribution of hyaluronan
and CD44 by renal tubular cells.
Methods. Madin-Darby canine kidney (MDCK) strain I and
primary cultures of human renal tubular cells were grown
on permeable supports in a two-compartment culture system.
Studies were performed during growth and after scrape-injury.
Metabolic labeling studies and an enzyme-linked hyaluronan
-binding assay were used to measure the molecular mass and
the amount of secreted hyaluronan in apical and basal medium.
Confocal microscopy was applied to detect membrane hyaluro-
nan and CD44. Hyaluronan synthase (HAS) mRNA expression
was studied with reverse transcriptase-polymerase chain reac-
tion (RT-PCR). The in vitro expression profile of hyaluronan
was compared with that in biopsies of transplanted human kid-
neys with acute tubular necrosis.
Results. Proliferating cells produced more hyaluronan (Mr >
106 Da) than growth-inhibited cells in intact monolayers and up
to 85% was targeted to the apical compartment, which was ac-
companied by increased HAS2 mRNA expression and slightly
decreased HAS3 mRNA, while HAS1 mRNA remained un-
detectable. Hyaluronan and CD44 were exclusively expressed
at the apical surface of proliferating/regenerating cells. After
(re)establishment of tight junctions, hyaluronan was no longer
detectable while CD44 was targeted to basolateral membrane
domains. In vivo in inflamed human kidneys hyaluronan was
abundantly expressed in the cortical tubulointerstitial space as
well as at the luminal surface of regenerating renal tubular
cells.
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Conclusion. These results demonstrate that the production
of hyaluronan by renal tubular cells is activated during prolifer-
ation and in response to mechanical injury and that hyaluro-
nan and CD44 expression is highly polarized. The targeted
delivery of hyaluronan to the apical compartment suggests that
hyaluronan produced by renal tubular cells supports prolifera-
tion/regeneration in the renal tubules, but that it does not con-
tribute to hyaluronan accumulation in the renal interstitium.
These data further support the concept that mitogen/stress-
induced hyaluronan deposition in the renal tubules increases
the risk for crystal retention and stone formation.
A kidney stone is composed of many small crystals in-
terspersed with organic material. Crystallization is the
unavoidable physicochemical consequence of the urinary
concentration process in the kidney and can not lead to
stone formation as long as precipitated stone salts are ef-
ficiently excreted with the urine. Renal stone formation
requires crystal retention. Previous studies indicate that
hyaluronan plays a key role in this process [1, 2]. Studies
with renal tubular epithelial cells in culture showed that
confluent monolayers of distal tubule/collecting duct-like
Madin-Darby canine kidney strain I (MDCK-I) cells are
nonadherent to calcium oxalate monohydrate crystals [3].
In contrast, crystals bind to cells in subconfluent cultures
and in confluent monolayers recovering from mechanical
injury [4]. The glycosaminoglycan hyaluronan was iden-
tified as a major crystal-binding molecule at the surface
of MDCK-I cells [1] and of human renal tubular cells in
primary culture [5]. In addition, it was found that in vivo
in rats that there is no crystal retention in the absence of
tubular injury/regeneration, but that crystals are retained
as soon as renal tubules are injured/regenerating. Crystals
were found adhered to the luminal surface of hyaluronan-
expressing injured/regenerating cells, therefore strongly
suggesting that crystal retention in the kidney requires
tubular epithelial injury accompanied by luminal expres-
sion of hyaluronan [2].
Hyaluronan (hyaluronic acid) is a glycosaminogly-
can (GAG) composed of repeating disaccharide units of
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glucuronic acid and N-acetylglucosamine [6]. The biosyn-
thesis of hyaluronan is unique, since most GAGs are
synthesized in the Golgi network and linked to a core pro-
tein to form proteoglycans, while hyaluronan is synthe-
sized at the plasma membrane as a free GAG. Hyaluro-
nan synthases (HAS) are localized at the inner face of
the plasma membrane and assemble a growing polymer
of hyaluronan which is extruded through the membrane
to the outside of the cell [7]. In mammalian cells three
different HAS genes have been identified, encoding for
three different HAS proteins, HAS1, HAS2, and HAS3.
HAS1 drives the synthesis of high Mr hyaluronan and
has been proposed as a “housekeeping” HAS. HAS2 also
produces high Mr hyaluronan and is activated during em-
bryonic development and inflammation. HAS3 drives the
synthesis of short proinflammatory hyaluronan chains.
Hyaluronan plays important roles in morphogenesis, tis-
sue remodeling, inflammation, and cancer [6]. In many
cell types hyaluronan binds to the extracellular domain
of specific cell surface receptors such as CD44 to form cell
coats or pericellular matrices (PCMs). CD44-hyaluronan
interaction also directly activates intracellular signaling
pathways [8–10].
In healthy kidneys, hyaluronan is hardly expressed in
the cortex, but abundantly present in the medullary inter-
stitium where it is involved in diluting/concentrating the
urine [11, 12]. The expression of hyaluronan is strongly
up-regulated in the cortex during various inflammatory
renal disease states, such as immune-mediated renal tis-
sue injury [13] allograft rejection [14], and ethylene glycol
intoxication [2]. Increased hyaluronan expression is pre-
dominantly reported in the cortical interstitium, but in
ethylene glycol–treated rats hyaluronan not only accu-
mulated in the renal interstitium, but also at the luminal
membrane of tubular epithelial cells [2].
MDCK-I and primary cultures of human renal tubu-
lar cells express hyaluronan at subconfluence, but not at
confluence [1, 5, 15]. Since crystal retention depends on
the expression of hyaluronan at the apical surface and
not on the basolateral plasma membrane, we here stud-
ied the polarized distribution of hyaluronan and CD44
in MDCK-I and primary cultures of human renal tubu-
lar cells during various growth stages and in response to
mechanical damage. Cells were cultured on permeable
supports in a two-compartment culture system to have
free access to both apical and basal culture medium. The
results show that mitogen/stress-activated cells are trig-
gered to synthesize increased levels of high Mr hyaluro-
nan which is predominantly secreted into the apical
medium compartment. Activated cells express hyaluro-
nan and CD44 at the apical but not at the basolateral
membrane, while at confluence or after wound healing
hyaluronan is not detectable and CD44 directed to the
basal membrane. Increased hyaluronan biosynthesis is
accompanied by increased levels of HAS2 mRNA ex-
pression, while the expression of HAS3 mRNA is slightly
down-regulated. Our cells did not express HAS1 mRNA.
During acute renal failure in humans, hyaluronan accu-
mulated in the renal corticointerstitium but was also ob-
served at the luminal surface of renal tubular cells. These
results indicate that the increased production of high
Mr hyaluronan by mitogen/stress-activated renal tubular
cells is destined for the apical surface and that the expres-
sion of hyaluronan and CD44 is highly polarized under
these conditions. This suggests that the increased synthe-
sis of hyaluronan by activated renal tubular cells during
inflammatory disease states does not contribute to the
up-regulated expression of hyaluronan in the renal inter-
stitium. These data further support the concept that the
elimination of precipitated stone salts for the kidney is
impeded by mitogen/stress-induced hyaluronan expres-
sion in the renal tubules.
METHODS
Cell culture
MDCK-I cells were kindly provided by Prof. Dr. G.
van Meer, Department of Cell Biology and Histology,
Academic Medical Center, University of Amsterdam,
The Netherlands. This strain is isolated from the origi-
nal American Type Culture Collection MDCK cell line
and resembles cortical collecting ducts segments [16].
The cells were routinely grown in plastic tissue culture
flasks (Corning Costar Corporation, Badhoevedorp, The
Netherlands) at 37◦C in a humidified atmosphere of 5%
CO2 in air. Subculturing was performed weekly by releas-
ing the cells from the culture flasks by incubation with
0.05% (wt/vol) trypsin and 0.02% (wt/vol) ethylenedi-
aminetetraacetic acid (EDTA) (Bio Whittaker, Verviers,
Belgium). The cells were cultured in Dulbecco’s modi-
fied minimal essential medium (DMEM) (Gibco, Grand
Island, NY, USA) supplemented with 10% fetal calf
serum (FCS) (PAA Labs, Linz, Austria), 2 mmol/L L-
glutamine, 100 lg/mL streptomycin, and 100 IU/mL
penicillin.
Primary cultures of human renal cortical tubular cells
were used as previously described [17, 18]. Briefly,
cells were obtained from tumor nephrectomy speci-
mens, which was permitted by the Ethical Committee of
the University of Antwerp. Macroscopically normal tis-
sue was decapsulated. Cortex and outer stripe of outer
medulla were dissected, cut into pieces of ±1 mm3 and
digested in collagenase D solution (Roche, Ottweiler,
Germany), supplemented with DNAse (Sigma Chemical
Co., St Louis, MO, USA). The suspension was shaken vig-
orously for 2 hours at 37◦C and sieved through a 120 lm
sieve. The resulting cell suspension was loaded on top of
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a discontinuous Percoll (Amersham Pharmacia Biotech,
Uppsala, Sweden) gradient with densities 1.04 and 1.07
g/mL. After centrifugation, cells from the intersection
were carefully aspirated, washed and brought into culture
in a-minimal essential medium (MEM) (Life Technolo-
gies, Rockville, MD, USA) modified according to Gibson
d’Ambrosio et al [19] supplemented with 10% FCS. In
mixed cultures proximal and distal tubular cells are recog-
nized with segment-specific membrane markers. Leucine
amino peptidase (LAP) was used for proximal tubular
cells and epithelial membrane antigen (EMA) for distal
tubular cells. Initially, subconfluent cultures of primary
human tubular cells contain equally as much proximal as
distal tubular cells. Interestingly, confluent mixed cultures
appeared to consist almost entirely of EMA-positive cells
that are no longer susceptible to crystal binding [5]. Thus
primary cultures of human renal cortical tubular cells be-
come enriched with distal tubular during their develop-
ment into intact monolayers.
The cells used in these experiments were checked to
be free from mycoplasma contamination.
Growth studies
Cells were cultured on permeable polycarbonate Tran-
swell filter inserts (insert growth area 4.7 cm2, 0.4 lm pore
size) (Costar) (Corning Costar Corporation). MDCK-I
and primary cultures of renal tubular cells were seeded at
a plating density of 1.0 × 106 cells/insert and cultured on
these permeable supports in a two-chamber system. The
total amount of cells/insert was determined at time inter-
vals of 2 days by counting the cells in a hemocytometer.
To monitor the assembly of tight junctions, transepithe-
lial electrical resistances (TERs) were measured with an
Epithelial Tissue Volt-ohm-meter connected to an
Endohm-24 tissue resistance measurement chamber
(World Precision Instruments; Sarasota, FL, USA). Since
cells are seeded at a high density, both subconfluent and
confluent cultures morphologically appear as a continous
row of cells. Cell cultures were considered confluent when
the total number of cells/insert did not further increase
and maximal TER values had developed.
Wound healing studies
Cells were grown to confluence and subsequently in-
jured by scraping off 100 to 150 mm2 (approximately
one third of the total filter area) with the tip of a ster-
ile 10 mL tissue culture pipette. Subsequently, the filters
were washed with phosphate-buffered saline (PBS), fresh
medium was added to the cells, and the process of wound
healing monitored morphologically by light microscopy
and functionally by measuring TERs.
Metabolic labeling studies
The production of high Mr hyaluronan was determined
in subconfluent (1 day postseeding) and in confluent
(7 days postseeding) MDCK-I cultures by a metabolic
labeling protocol using radiolabeled [3H] glucosamine
(D-1-[3H] GlcNAc hydrochloride) (Amersham Phar-
macia Biotech, Roosendaal, The Netherlands) in
combination with enzymatic digestion and Sephacryl
S-1000 size exclusion chromatography. Cells in culture
flasks were cultured overnight in modified DMEM
with a reduced glucose content (1 mg/mL), after which
they were trypsinized, seeded at a concentration of 1 ×
106/insert/insert, cultured for 1 day, and metabolically
labeled for 24 hours with 2 lCi/mL [3H] GlcNAc (sub-
confluence). Cells were also seeded at a concentration
of 1 × 106/insert/insert, cultured for 6 days in DMEM
10% FCS, incubated overnight in modified DMEM
with a reduced glucose content (1 mg/mL), and than
metabolically labeled for 24 hours with 2 lCi/mL [3H]
GlcNAc (confluence). One and 7 days postseeding, the
average cell density subsequently was 0.9 × 106 and 4 ×
106 cells/insert. After metabolic labeling, the apical and
basolateral medium fractions (1500 and 2600 lL) were
divided in three portions of 500 lL. To distinguish
between hyaluronan and other secreted glycoconjugates,
we subjected these portions of the apical and baso-
lateral medium to differential enzyme digestion. One
portion was left untreated (control) to assess total glyco-
conjugate production. The second portion was incubated
with papain overnight to digest proteins in the sample
and not the papain-resistant polysaccharide hyaluronan.
Papain (E.C. 3.4.22.2) (Sigma-Aldrich Chemie,
Zwijndrecht, The Netherlands) was used at a final
concentration of 5 U/mL at 60◦C, pH 6.0. To check if the
papain-resistant fraction indeed consisted of hyaluronan,
the third portion was treated with papain as described
above, followed by additional treatment with 5 U/mL
Streptomyces hyaluronidase for 1 hour at 37◦C. Of the
various fractions, 150 lL was subsequently applied to
a 13 × 60 mm Sephacryl S-1000 column (Amersham
Biosciences) and eluted with 0.05 mol/L Tris, 0.15 mol/L
NaCl (pH 10), with 250 lL fraction volumes. The elution
pattern showed two major peaks, the first consisting of
high Mr [3H] GlcNAc–labeled molecules (>106 Da),
and the second with smaller molecules (<106 Da). High
Mr molecules were run-through in the early fractions
6 to 12, whereas smaller molecules were retarded by
the column to be collected later in fractions 13 to 30.
Accordingly, free precursor [3H] GlcNAc was entirely
recovered in these late fractions.
Cell surface-associated [3H] GlcNAc-labeled hyaluro-
nan was determined by measuring the release of radi-
olabel during 5 minutes of incubation of the cells with
fresh serum-free DMEM with or without Streptomyces
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Primer Sequence (5' to 3') Position
Fig. 1. The position of the oligonucleotide primers are based on human mRNA sequences.
hyaluronidase. Additional release of [3H] GlcNAc by the
enzyme-treated cells, compared to the spontaneous re-
lease by cells incubated without enzyme, was considered
to represent cell surface-associated hyaluronan.
Reverse transcriptase-polymerase chain reaction
(RT-PCR) studies
Primer pairs were designed to selectively amplify ei-
ther HAS1, HAS2, or HAS3 based on published species-
conserved sequences (Amersham Pharmacia Biotech
Inc.). Primer sequences are listed below (Fig. 1). Total
RNA and genomic DNA were isolated from subconfluent
and confluent MDCK-I cells using, respectively, RNA-
Bee RNA Isolation Solvent (Tel-Test Inc., Friendswood,
TX, USA) and PurGene genomic isolation kit (BioPlas-
tics, Landgraaf, The Netherlands) following the manu-
facturer’s protocol. RNA was reverse transcribed using
Maloney-murine leukemia virus (M-MLV) Reverse Tran-
scriptase (Invitrogen, Breda, The Netherlands) and poly-
T priming. Thirty cycles of PCR were performed using
isoform-specific primers for HAS2 and POLR2A (RNA
Polymerase II, large subunit) using either cDNA, ge-
nomic DNA as a positive control, or nonreverse tran-
scribed mRNA as a negative control. HAS1 and HAS3
primers needed 35 cycles of PCR to detect an appropriate
amount of DNA. In the case of HAS1 RT-PCR, mouse
cDNA served as a second positive control. PCR prod-
ucts were visualized under ultraviolet light after gel elec-
trophoresis in 2% agarose containing ethidium bromide.
Confocal laser scanning microscopy (CLSM)
Cells were fixed in formaldehyde/glutaraldehyde
(3.7%/0.1%, vol/vol) for 10 minutes. Subsequently, cells
were incubated for 60 minutes with 3% (wt/vol) low-fat
dry milk in PBS/0.1% Tween-20 to block nonspecific
binding. Cells were washed and incubated overnight at
4◦C with 2% biotinylated hyaluronan-binding protein
(bHABP) (Seikagaku Inc., Tokyo, Japan), rat anticanine
CD44 (Serotec, Oxford, UK) or purified antimouse CD44
(IM7) (Becton Dickinson Biosciences Pharmingen,
Woerden, The Netherlands) followed by the appropriate
secondary labels, respectively, fluorescein isothiocyanate
(FITC)-conjugated avidin (fluorescein avidin D)
(Vector Laboratories Inc., Burlingame, VT, USA),
FITC- or TRITC-conjugated rabbit antirat IgG (H + L)
(Southern Biotechnology Associates Inc., Birmingham,
AL, USA), or FITC- or TRITC-conjugated rabbit anti-
mouse IgG (Dako, Glostrup, Denmark). Occasionally,
the stainings were combined with a propidium iodide
counterstaining to localize cell nuclei. Filters were
mounted in vectashield and analyzed with a Zeiss LSM
410 CLSM (Zeiss, Oberkochen, Germany). A 488 nm
Ar-laser was used to excitate FITC and a 543 nm laser to
excitate TRITC or propidium iodide.
5-bromo-2′-deoxyuridine (BrdU) staining
To incorporate BrdU during wound healing, the cells
were incubated for 2 hours with 30 lg/mL BrdU (Sigma
Chemical Co.) in culture medium 10% FCS at 37◦C
in a humidified incubator 5% CO2 in air. The inserts
were washed with physiologic saline and fixed in 70%
ethanol. The cells were subsequently incubated overnight
with primary mouse monoclonal BrdU antibody IIB5
(1:20) (Euro-Diagnostica B.V., Arnhem, The Nether-
lands) at 4◦C after which they were incubated with bi-
otinylated secondary antibody (1:400) (Dako) at room
temparature for 1 hour. Immunoreactivity was visual-
ized by staining with streptavidin-peroxidase complex
(1:50) (BioGenex, San Ramon, CA, USA) and 3,3-
diaminobenzidine (DAB) (Dako) and cells were coun-
terstained with hematoxylin.
Quantitation of hyaluronan production
The concentration of hyaluronan in culture medium
was determined with a commercial quantitative kit, which
is based on the specific binding of HABP with hyaluro-
nan (Corgenix HA Test Kit, Denver, CO, USA). Medium
of both the apical and basal compartment were collected
after the indicated periods of time during growth and
wound healing studies. This assay method measures all
hyaluronan in the sample and does not discriminate be-
tween long or short hyaluronan chains.
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Fig. 2. Production of high Mr glycoconju-
gates by Madin-Darby canine kidney strain
I (MDCK-I) cells cultured on permeable sup-
ports in a two-compartment culture system,
and analyzed by metabolic labeling studies
using [3H] glucosamine in combination with
specific enzyme digestion and Sephacryl S-
1000 size exclusion chromatography. Prolif-
erating cells in subconfluent cultures deliver
relatively large amounts of high Mr [3H]
glucosamine-labeled glycoconjugates into the
apical compartment of which the far major-
ity is hyaluronidase-digestible (A), whereas
at this point in epithelial development much
smaller amounts of hyaluronidase-digestible
macromolecules are delivered into the basal
medium (B). Growth-inhibited cells in con-
fluent cultures deliver only samll amounts of
hyaluronidase- and papain-digestible macro-
molecules into the apical compartment (C),
while confluent monolayers no longer se-
crete molecules >106 Da into the basal com-
partment (D). Symbols are: (), untreated;
(), papain-treated; (), papain pretreated +
hyaluronidase treated.
Hyaluronan staining of human renal tissue
Renal biopsy tissue specimens of patients suffering
from posttransplantation acute tubular necrosis were
stained for hyaluronan as described previously [2].
Briefly, tissue was fixed in formaldehyde 4% and paraffin
embedded. Sections were blocked with 1% bovine serum
albumin (BSA) for hyaluronan staining and incubated
with bHABP. Avidin-biotin peroxidase complex (Vector
Laboratories) and DAB were used to detect hyaluronan.
Nuclei were counterstained with methyl green. No stain-
ing was observed when bHABP was omitted.
RESULTS
Hyaluronan biosynthesis analyzed in metabolic
labeling studies
Subconfluent and confluent MDCK-I cultures were
metabolically labeled overnight with [3H] GlcNAc af-
ter which culture medium in the apical and basal com-
partment was collected to assess the relative amount of
[3H] GlcNAc incorporated in macromolecular glycocon-
jugates. Subconfluent cultures secreted relatively large
amounts of radioactively labeled high Mr molecules into
the apical compartment, whereas much smaller amounts
were secreted into the basal compartment (Fig. 2). The
production of high Mr glycoconjugates by confluent
monolayers was ∼20-fold lower and delivered into the
apical medium. Only a relatively small amount of high
Mr glycoconjugates produced by subconfluent cultures
could be degraded with papain, whereas practically the
remaining high Mr molecules could be digested by Strep-
tomyces hyaluronidase. Thus, proliferating MDCK-I cells
produced high Mr glycoconjugates of which the majority
consisted of hyaluronan. Considering their size, most
papain-sensitive glycoconjugates consist of proteogly-
cans. Although relatively small differences were observed
in the secretion of papain-sensitive molecules (ratio api-
cal basal medium 2:1), most hyaluronidase-digestable
glycoconjugates were delivered almost exclusively into
the apical compartment (ratio apical basal medium 7:1)
(Fig. 2).
To assess the amount of cell surface-associated [3H]
GlcNAc-labeled glycoconjugates metabolically labeled
MDCK-I cells in subconfluent and in confluent cul-
tures were treated with hyaluronidase. Hyaluronidase
was more effective in releasing radiolabel from subcon-
fluent cultures (Fig. 3).
Quantitation of hyaluronan production
An enzyme-linked HABP assay was applied to mea-
sure the amount of hyaluronan in the apical and
basal medium bathing MDCK-I cells during the heal-
ing of wounds made in confluent monolayers. Confluent
monolayers of MDCK-I cells synthesized relatively low
amounts of hyaluronan (Fig. 4). After scrape-damaging
intact monolayers the production of hyaluronan was
strongly up-regulated. During regeneration, most of the
de novo produced hyaluronan, was targeted to the api-
cal compartment (Fig. 4). The apical versus basal ratios
however were lower than those in the metabolic labeling
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Fig. 3. Streptomyces hyaluronidase ()-cleavable [3H] glucosamine in-
corporated in cell surface gylcoconjugates of subconfluent and conflu-
ent Madin-Darby canine kidney strain I (MDCK-I) cells grown on cul-
ture system compared to spontaneous release of [3H]-glucosamine in
DMEM alone.
studies suggesting that a considerable part of hyaluronan
measured with the quantitative assay method consisted of
shorter hyaluronan chains. The synthesis of hyaluronan
normalized to the levels in undamaged controls as soon
as the wound were healed and monolayers reestablished
high TERs.
Four days after the initiation of primary cultures of
human renal tubular cells, culture medium of the api-
cal and basal compartment was collected every 48 hours
and replaced with fresh medium. The highest amount of
hyaluronan was measured at subconfluence (i.e., the sec-
ond time that medium was replaced) (Fig. 5). Also in pri-
mary cultures most synthesized hyaluronan was secreted
into the apical compartment (Fig. 5).
RT-PCR studies
Expression of HAS1, HAS2, and HAS3 mRNA in sub-
confluent and confluent MDCK-I cultures was assessed
with RT-PCR using specific primers designed to amplify
species-conserved HAS1, HAS2, and HAS3 sequences.
Primers were designed for POLR2A for the normaliza-
tion of RNA levels. Using HAS2 primers, a prominent
product of the expected size from both cDNA and ge-
nomic DNA was evident after 30 cycles of PCR (and
not noted in the negative control). Sequence analysis of
the product confirmed the expression of HAS2 mRNA
(Fig. 6). According to these results, HAS2 is clearly up-
regulated in subconfluent MDCK-I cells. The designed
HAS3 primers were also able to amplify the expected
DNA fragment sizes from cDNA and genomic DNA,
but this time 35 cycles of PCR were required to detect
an appropriate amount of DNA. HAS3 sequences were
detected in these DNA fragments by sequence analysis.
According to these data there is a slight downregulation
of HAS3 in subconfluent MDCK-I cells (Fig. 6). Both
sequences of the HAS2 and HAS3 PCR products are
shown aligned with the published human sequence in
Figure 7. The homology of the canine HAS2 and HAS3
sequences to published sequences from other species
(including human, rat, mouse, and bull) is >92%. HAS1-
specific primers were unable to amplify any HAS1 prod-
uct from MDCK-I cDNA but did amplify HAS1 from
genomic DNA, although this fragment contains an in-
tron sequence. Also an amplification of HAS1 product
was obtained with mouse and human cDNA. All of the
DNA fragments had the expected sizes. Sequence analy-
sis of the DNA fragments of MDCK-I genomic DNA and
mouse cDNA confirmed the presence of HAS1 DNA se-
quences. From these findings it was concluded that HAS1
is hardly expressed in MDCK-I cells (not shown).
CLSM
Two days postseeding, when monolayers still have low
TERs (∼200  cm2), bHABP bound to the entire apical
cell surface, but not at basolateral domains. This apical
staining was less prominent after 4 days when cultures ap-
proached confluence and were actively assembling tight
junctions (TER ∼3000  cm2). After 6 days the TERs
were maximal high (>5000  cm2) and bHABP did not
bind to the cell surface (Fig. 8).
Confluent MDCK-I monolayers did not express
hyaluronan. After scrape injury, however, migrating cells
at the border of the wound became flattened and again
expressed hyaluronan at their membrane (Fig. 9A and B),
while cells in undamaged areas did not express hyaluro-
nan. After the wounds were healed and tight junctions
were reestablished hyaluronan again disappeared from
the cell surface.
Two days postseeding CD44 was expressed exclusively
at the apical surface of cells (TERs ∼200  cm2). Four
days postseeding (TERs ∼3000  cm2) CD44 was pre-
dominantly found in the lateral space between the cells.
Six days postseeding (maximal high TERs >5000  cm2),
the membrane expression of CD44 was restricted to the
basal side of the monolayers. Thus, in MDCK-I cells dur-
ing their growth to confluence CD44 expression is polar-
ized, at first at the apical surface, subsequently at lateral
sites, and finally at the basal plasma membrane when tight
junction formation is fully established (Fig. 8). Double-
staining of CD44 (red) and hyaluronan (green) showed a
clear colocalization at the apical surface of proliferating
MDCK-I cells populating subconfluent cultures (Fig. 10).
In confluent monolayers, the expression of CD44 was
restricted to basal membranes. After scrape injury, mi-
grating cells at the border of the wounds began to express
CD44 at their apical membrane (Fig. 9C and D). After
the wounds were healed and TERs were reestablished,
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Fig. 4. Quantitative determination of hyaluronan by an enzyme-linked binding protein assay in the apical and basal compartment of intact Madin-
Darby canine kidney strain I (MDCK-I) monolayers (A) and during the healing of wounds made in confluent monolayers (B), grown on permeable
supports in a two-compartment culture system. Hyaluronan was measured in daily replaced Dulbecco’s modified Eage’s medium (DMEM) supple-
mented with 10% fetal calf serum (FCS) on 1, 2, 3, and 4 days postconfluence or postinjury (A and B) and without replacing the culture medium
(C). Wound closure was monitored by transepithelial electrical resistance (TER) measurements (D).
CD44 expression was again selectively targeted to the
basal membrane.
BrdU staining
To reveal if the cells at the border of a scrape wound are
proliferating, 1 day postinjury mechanically damaged cul-
tures were incubated with the proliferation marker BrdU.
This study showed that the cells stained positively for
BrdU somewhat distal from the wound, but that BrdU
staining was hardly observed in the infiltrating flattened
cells at the border of the wound, indicating that these are
migrating rather than proliferating cells (Fig. 9E).
Hyaluronan staining in human renal tissue
Acute tubular necrosis is a pathologic condition that
is characterized by massive damage and regeneration of
tubular epithelial cells, processes which are known to take
place concurrently in the kidney [20]. Hyaluronan stain-
ing in renal tissue biopsy specimens not only showed an
up-regulated expression in the cortex but also that regen-
erating tubular cells in vivo express hyaluronan at their
apical membrane (Fig. 11).
DISCUSSION
This study shows that subconfluent cultures formed
by MDCK-I cells and primary cultures of human re-
nal tubular cells synthesize higher amounts of hyaluro-
nan than confluent cultures. The increased production
of hyaluronan by proliferating cells is accompanied by
increased expression of HAS2 mRNA, while HAS3 is
slightly down-regulated and HAS1 remains undetectable.
The increased hyaluronan production is polarized since in
both cell types, hyaluronan is secreted predominantly into
the apical medium compartment. During wound healing,
regenerating renal tubular cells also secreted increased
amounts of hyaluronan into the apical compartment.
Hyaluronan is expressed at the apical, but not the baso-
lateral membrane of proliferating or regenerating cells,
indicating that the membrane expression of hyaluronan
is polarized as well. The apical expression of hyaluronan
was invariably accompanied with the apical expression of
CD44. At confluence or after wound healing, hyaluronan
as well as CD44 is no longer detectable at the apical sur-
face. Hyaluronan entirely disappeared, while CD44 was
targeted to basal domains of the plasma membrane.
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Fig. 5. Determination of hyaluronan by enzyme-linked binding protein
assay (B) in the apical and basal compartment of primary cultures of
human renal tubular cells during their growth to confluence (A) on
permeable supports in a two-compartment culture system.
To our knowledge there is only one other report
dealing with the polarized secretion of hyaluronan by
epithelial cells [21]. The secretion of hyaluronan by con-
fluent retinal epithelial cells in primary culture grown on
permeable supports is also highly polarized, with 82% to
95% of the hyaluronan delivered into the apical medium.
Apparently, retinal pigment cells constitutively express
and deliver hyaluronan from the apical surface to sup-
port the interphotoreceptor matrix of the eye [21]. The
polarized expression and secretion of hyaluronan by re-
nal tubular cells is not constitutive, but restricted to pro-
liferating and regenerating cells, indicating that remod-
eling/regenerating renal tubular cells require hyaluronan
at the luminal side of the epithelium, while terminally
differentiated cells do not. From our study it is unclear
whether the relatively small amount of hyaluronan in the
basal compartment was secreted from the basal mem-
brane or derived from transepithelial leakage. The fact
that hyaluronan did not accumulate under the mono-
layers and that hyaluronan staining was found at the
apical cell surface and not between cells indicates that
the porous growth substrate was no barrier for hyaluro-
nan and that hyaluronan indeed is predominantly se-
creted from the apical membrane. Soon antibodies
directed against HASs will be available which will elu-
cidate the epithelial development-dependent subcellular
localization of the various HAS proteins. Remarkably,
the secretion/expression of hyaluronan and the expres-
sion of CD44 is polarized at times when the tight junctions
are not yet fully assembled. Although many membrane
proteins and lipids require functional tight junctions as a
diffusion barrier in the plane of the lipid bilayer, for other
membrane components cell-substratum and/or cell-cell
contact is sufficient to induce and maintain epithelial cell
surface segregation [22]. Apparently, tight junction for-
mation is not an absolute requirement for HAS and CD44
to be targeted to the apical plasma membrane. The po-
larized distribution of CD44 by MDCK cells was demon-
strated earlier, but in these studies CD44 did not entirely
reach the basal membrane [23, 24]. Most likely, our cells
obtained higher levels of terminal differentiation because
the confluent monolayers were kept in culture for a longer
period of time.
The interaction of hyaluronan with cell surface re-
ceptors such as CD44 and receptor for hyaluronan-
mediated motility (RHAMM) activates intracellular sig-
naling pathways during cell migration/proliferation [25].
Hyaluronan receptor binding also plays a role in anchor-
ing hyaluronan coats to the cell surface [26]. Also in our
study apical CD44 invariably colocalizes with hyaluro-
nan, suggesting receptor-ligand interaction [27]. The in-
teraction between CD44 and hyaluronan was studied
earlier in proliferating SV40-transformed mouse cortical
tubular (MCT) cells [28]. CD44 was randomly expressed
over the membrane and the cells constitutively bound
exogenously added hyaluronan. CD44-hyaluronan bind-
ing could be modulated with CD44 antibodies, suggest-
ing that CD44 indeed served as a hyaluronan recep-
tor. The polarized membrane distribution of CD44 was
not further addressed and it was not reported if MCT
cells were capable to synthesize and express endogenous
hyaluronan.
In an impressive series of recent publications Philips
et al [29] revealed several aspects of renal hyaluronan
biology using immortalized human proximal tubule hu-
man kidney 2 (HK-2) cells and human primary cultures
of proximal tubular cells. In agreement with our studies,
scrape-damaging HK-2 monolayers led to an increased
hyaluronan production, which in HK-2 cells appeared
to be mediated by the extracellular signal-regulated ki-
nase (ERK) pathway. HK-2 cell migration during wound
healing was increased by exogenous hyaluronan. In hu-
man proximal tubulular cells, HAS2 mRNA expression
and hyaluronan secretion could be stimulated with in-
terleukin (IL)-1b and high levels of glucose, but not by
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Fig. 6. Hyaluronan synthase (HAS) mRNA
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I (MDCK-I) cells. Reverse transcription-
polymerase chain reaction (RT-PCR) analysis
was performed using HAS2 and HAS3 gene-
specific primers as described in the Methods
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Fig. 7. Sequences of polymerase chain reac-
tion (PCR) products from hyaluronan syn-
thase 2 (HAS2) and HAS3 reverse transcrip-
tase (RT)-PCR (canine) are shown aligned
with the human sequences. The canine HAS1
PCR product was not detectable and could not
be sequenced. Underlined segments indicate
the sites of primer annealing. (A) Sequence
of PCR product for HAS2. (B) Sequence of
PCR product from HAS3.
transforming growth factor-b (TGF-b) or other growth
factors. In this study, HAS2 mRNA expression was in-
ducible, whereas HAS3 was consitutively expressed and
HAS1 was undetectable. This HAS expression pattern
is identical to that found by us in activated MDCK-I
cells. The activated transcription of HAS2 in activated
proximal tubular cells was coupled to the transcription
factor nuclear factor-jB (NF-jB) [30]. IL-1b and high
glucose also influenced the functional behavior of cell
surface CD44 leading to increased hyaluronan binding
and uptake [31]. The hyaluronan production and ex-
pression by confluent HK-2 cells was also stimulated
by bone morphogenic protein-7 (BMP-7). Among other
things, this type of stimulation increased the amount of
HAS2-mediated cell surface hyaluronan, decreased the
expression of hyaluronidases and increased the binding of
monocytes to the cell surface [32]. In HK-2 cells, the syn-
thesis of extracellular matrix molecules collagen III and
IV were activated with TGF-b , which could be blocked
with CD44 antibodies, mitogen-activated protein (MAP)
kinase inhibitors or hyaluronan [33]. CD44- hyaluronan
also decreased TGF-b1–dependent proximal tubular cell
functions [34]. Collectively, these results suggest that
hyaluronan performs various functions during inflamma-
tory renal disease states.
There are some important differences between the
studies performed by Philips et al and our studies. HK-
2 cells constitutively express hyaluronan, while our cells
express hyaluronan only after some form of activation.
Since hyaluronan is not expressed by renal tubular cells in
healthy kidneys, this suggests that HK-2 cells are contin-
uously activated, a phenomenon typical for immortalized
cells or cancer cells. While we culture our cells on porous
supports in a two compartment culture system, the HK-2
cells are cultured on conventional solid growth substrates.
This makes it difficult to appreciate if the various ago-
nists and extracellular and pericellular matrix molecules
exerted their effects at the apical or basolateral plasma
membrane. In agreement with activated HK-2 cells, stim-
ulation of MDCK-I cells leads to an increased production
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Fig. 8. Confocal microscopy images of
the membrane localization of hyaluronan
[biotinylated hyaluronan binding pro-
tein (bHABP)-fluorescein isothiocyanate
(FITC) + propidium iodide] (A) and C44
(IM7-FITC) (B) during the development
of Madin-Darby canine kidney strain I
(MDCK-I) cultures into confluent monolay-
ers with functional tight junctions (C). TER
is transepithelial electrical resistance.
Fig. 9. Confocal microscopic images of
hyaluron [biotinylated hyaluron binding
protein (bHABP)-fluorescein isothiocyanate
(FITC)] (A and B) and CD44 (IM7-FITC)
(C and D) expressed by flattened cells at
the border of the wound. B and D are scans
made perpendicular to the cultures (xz
scans) showing flattened cells infiltrating the
denuded areas. (E) Light microscopic image
of 5-bromo-2′-deoxyuridine (BrdU)-stained
cells during wound healing showing few
BrdU-positive cells at the leading edge of
the wound and abundant staining in areas
somewhat distant from the wound. This
BrdU staining indicates that the falttened
cells at the border of the wound are migrating
cells rather than proliferating cells.
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Fig. 11. Hyaluronan staining in the cortex of a renal tissue biopsy specimen of a patient suffering from acute tubular necrosis, showing expression
of hyaluronan at the luminal membrane of tubular cells and also in the cortical interstitium. Arrows indicate hyaluronan expressed at the luminal
cell membrane (×1000 magnification).
Fig. 10. Confocal microscopy xy and xz images showing the colocaliza-
tion of hyaluronan [biotinylated hyaluron binding protein (bHABP)-
fluorescein isothiocyanate (FITC) (green) and its major cell surface
receptor CD44 [IM7-TRITC] (red) at the apical plasma membrane of
of (high Mr) hyaluronan and increased levels of HAS2
mRNA.
The expression of hyaluronan is up-regulated in the
cortical interstitium during various inflammatory renal
disease states [2, 13, 14]. It was only recently reported
that the expression of hyaluronan in kidneys of ethy-
lene glycol treated rats was not only increased in the
renal interstitium, but that hyaluronan also appeared at
the luminal surface of the epithelial cells lining the renal
tubules [2]. This expression of hyaluronan by renal tubu-
lar cells could be overlooked in the past due to the over-
whelming hyaluronan expression in the interstitium, or
by the removal of cell surface hyaluronan by fixation and
washing procedures [35]. Here, it is shown that in mildly
ﬁxed and washed renal biopsy specimens of patients with
acute tubular necrosis, the expression of hyaluronan is not
only up-regulated in the cortical interstitium, but also at
the luminal surface of renal tubular cells (Fig. 10). Since
subconfluent cultures of Madin-Darby canine kidney strain I (MDCK-
I) cells grown on a permeable support in a two-compartment culture
system.
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acute tubular necrosis is accompanied by tubular dam-
age and regeneration [20], this suggests that also in the
human kidney, hyaluronan is expressed by regenerating
renal tubular cells. The source of hyaluronan in the cor-
tical interstitium remains unclear. Although we cannot
entirely exclude some apical-to-basal hyaluronan leak-
age our results suggest that renal tubular cells are not
the main source for hyaluronan in the renal interstitium.
Perhaps interstitial fibroblasts account for most of the
newly formed hyaluronan during acute renal inflamma-
tion. The engagement of CD44 and hyaluronan in the re-
nal tubules may communicate with and thereby activate
interstitial cells through signal transduction pathways, or
interstitial fibroblasts are triggered by low Mr hyaluro-
nan secreted from the basolateral membrane of stress-
activated renal tubular cells. It has been demonstrated
that normal rat cortical and medullary fibroblasts in cul-
ture are capable to synthesize hyaluronan [36]. Another
possibility is that during inflammation tubular epithe-
lial cells become fibroblasts via epithelial to mesenchy-
mal transdifferentiation [37]. This is entirely speculative,
however, and additional studies are required using ap-
propriate model systems to investigate this issue more in
detail.
Our interest in hyaluronan production and expression
by renal tubular cells came from investigations into the
possible involvement of renal tubular cells in the patho-
physiology of nephrolithiasis. Renal stones can only form
when crystals somehow are retained in the kidney. It was
found that (calcium oxalate) crystals bind to renal tubular
cells in subconfluent, but not in confluent cultures [1, 4].
Hyaluronan was identified as crystal binding molecule [1].
Recently, we studied this concept in rats treated with ethy-
lene glycol, a nephrotoxic and (calcium oxalate) crystal-
inducing agent [2]. Although ethylene glycol almost
immediately resulted in crystalluria, several days were
required for the renal tubular epithelium to become dam-
aged/regenerate and crystals to be retained. In agreement
with our in vitro data, crystals deposited in the tubules
were closely associated with regenerating cells that ex-
pressed hyaluronan and CD44 at their luminal surface.
Studies are underway in which we will explore possibili-
ties to inhibit the proliferation/stress-induced expression
of hyaluronan by renal tubular cells in culture and in rats,
aimed at limiting or preventing accumulation of crystals
in the kidney.
The results of the present study show that hyaluro-
nan biosynthesis is activated during proliferation and in
response to mechanical injury and that the membrane
distribution of hyaluronan and CD44 is highly polarized
despite the absence of functional tight junctions. The tar-
geted delivery of hyaluronan to the apical medium com-
partment suggests that hyaluronan supports cell growth
and remodeling in the renal tubules. These data further
support the concept that mitogen/stress-induced hyaluro-
nan deposition in the renal tubules increases the risk for
crystal retention.
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